These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11469510)

  • 1. The pharmacokinetics of a long-acting oxytetracycline formulation in healthy dogs and in dogs infected with Ehrlichia canis.
    Kikuvi GM; Mitema ES; Buoro IB
    Vet Res Commun; 2001 Jul; 25(5):391-400. PubMed ID: 11469510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some pharmacokinetic parameters and dosage regimens for a long-acting formulation of oxytetracycline in 6- to 8-month-old male calves.
    Kumar R; Malik JK
    Vet Res Commun; 1998 Dec; 22(8):533-44. PubMed ID: 10066127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of experimentally induced theileriosis (Theileria annulata) on the pharmacokinetics of a long-acting formulation of oxytetracycline (OTC-LA) in calves.
    Kumar R; Malik JK
    J Vet Pharmacol Ther; 1999 Oct; 22(5):320-6. PubMed ID: 10597536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition of oxytetracycline in pigs after i.m. administration of two long-acting formulations.
    El Korchi G; Prats C; Arboix M; Pérez B
    J Vet Pharmacol Ther; 2001 Aug; 24(4):247-50. PubMed ID: 11555179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic disposition of a long-acting oxytetracycline formulation after single-dose intravenous and intramuscular administrations in the American alligator (Alligator mississippiensis).
    Helmick KE; Papich MG; Vliet KA; Bennett RA; Jacobson ER
    J Zoo Wildl Med; 2004 Sep; 35(3):341-6. PubMed ID: 15526889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental and clinical trials of long acting oxytetracycline in the treatment of canine ehrlichiosis.
    Ogunkoya AB; Adeyanju JB; Abduhllahi R
    Vet Q; 1985 Apr; 7(2):158-61. PubMed ID: 3892880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition of oxytetracycline in pigs after i.m. administration of two long-acting formulations.
    Lees P; Gettinby G; Toutain PL
    J Vet Pharmacol Ther; 2002 Jun; 25(3):237-8. PubMed ID: 12081620
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of Short- and Long-acting Formulations of Oxytetracycline After Intramuscular Administration in Chickens.
    Gberindyer AF; Okpeh ER; Semaka AA
    J Avian Med Surg; 2015 Dec; 29(4):298-302. PubMed ID: 26771319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum pharmacokinetics and tissue and milk residues of oxytetracycline in goats following a single intramuscular injection of a long-acting preparation and milk residues following a single subcutaneous injection.
    Payne MA; Babish JG; Bulgin M; Lane M; Wetzlich S; Craigmill AL
    J Vet Pharmacol Ther; 2002 Feb; 25(1):25-32. PubMed ID: 11874523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of a long-acting oxytetracycline-polyethylene glycol formulation in horses.
    Dowling PM; Russell AM
    J Vet Pharmacol Ther; 2000 Apr; 23(2):107-10. PubMed ID: 10849256
    [No Abstract]   [Full Text] [Related]  

  • 11. The pharmacokinetics of a long-acting formulation of oxytetracycline in sheep and goats.
    Escudero E; Carceles CM; Ponferrada C; Baggot JD
    J Vet Pharmacol Ther; 1996 Feb; 19(1):75-7. PubMed ID: 8992031
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of the pharmacokinetics and local tolerance of three injectable oxytetracycline formulations in pigs.
    Banting AL; Baggot JD
    J Vet Pharmacol Ther; 1996 Feb; 19(1):50-5. PubMed ID: 8992026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of two different oxytetracycline treatments in experimental Ehrlichia phagocytophila infected lambs.
    Stuen S; Bergström K
    Acta Vet Scand; 2001; 42(3):339-46. PubMed ID: 11887394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxytetracycline plasma levels in dogs after intramuscular administration of two formulations.
    Immelman A; Dreyer G
    J S Afr Vet Assoc; 1981 Sep; 52(3):191-3. PubMed ID: 7310789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of long-acting oxytetracycline in fallow deer (Dama dama).
    Haigh JC; Dowling PM; Smits JG
    J Vet Pharmacol Ther; 1997 Jun; 20(3):243-5. PubMed ID: 9185093
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics of oxytetracycline after intramuscular administration with lidocaine in sheep, comparison with a conventional formulation.
    Moreno L; Serrano JM; Guimerá ME; Carceles CM
    Res Vet Sci; 1998; 65(3):209-13. PubMed ID: 9915145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition of a long-acting oxytetracycline formulation in Thai swamp buffaloes (Bubalus bubalis).
    Poapolathep S; Wongpanit K; Imsilp K; Tanhan P; Klangkaew N; Giorgi M; Poapolathep A
    J Vet Pharmacol Ther; 2017 Apr; 40(2):206-209. PubMed ID: 27597645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between oral fluid and plasma oxytetracycline concentrations after intramuscular administration in pigs.
    Gajda A; Jablonski A; Gbylik-Sikorska M; Posyniak A
    J Vet Pharmacol Ther; 2017 Dec; 40(6):e39-e44. PubMed ID: 28456999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of long acting oxytetracycline in the laboratory rat.
    Curl JL; Curl JS; Harrison JK
    Lab Anim Sci; 1988 Aug; 38(4):430-4. PubMed ID: 3184852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penetration of oxytetracycline into the nasal secretions and relationship between nasal secretions and plasma oxytetracycline concentrations after oral and intramuscular administration in healthy pigs.
    Bimazubute M; Cambier C; Baert K; Vanbelle S; Chiap P; Gustin P
    J Vet Pharmacol Ther; 2011 Apr; 34(2):176-83. PubMed ID: 21395609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.